The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published guidance for companies submitting a Manufacturing Authorisation application or variation on...06 January 2017
Webinar | Generic Drug Labeling, Product Liability, and the Changing FDA Regulatory Landscape
The webinar will take place Tuesday, March 11, 2014 at 2:00 p.m. ET.
Pending CLE certification:
This program is pending approval for CLE credit in New York and California. For all other jurisdictions, attendees will receive a Uniform Certificate of Attendance.
Note to NY Lawyers:
This program is appropriate for non-transitional lawyers, but not acceptable for newly admitted lawyers.
For any questions regarding this event, please contact Kristen Walker.
For the latest government regulatory developments please visit us at Focus on Regulation at www.hlregulation.com
On 16 December 2016, the European Medicines Agency (“EMA”), along with the European Biopharmaceutical Enterprises (“EBE”) organised the fifth annual regulatory...03 January 2017
On 8 December 2016, the European Medicines Agency (“EMA”) organised a workshop in collaboration with the European Commission to gather the views and proposals from stakeholders...03 January 2017